Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies

I Lilienthal, N Herold - International journal of molecular sciences, 2020 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumour in children and
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …

Pediatric osteosarcoma: an updated review

SJ Taran, R Taran, NB Malipatil - Indian Journal of Medical and …, 2017 - thieme-connect.com
Osteosarcoma (OS), the most common type of primary malignant bone tumor, is defined by
the presence of malignant mesenchymal cells producing osteoid or immature bone. The …

Biology and therapeutic advances for pediatric osteosarcoma

N Marina, M Gebhardt, L Teot, R Gorlick - The oncologist, 2004 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
etiologic and biologic factors in osteosarcoma. Select the appropriate diagnostic work-up for …

The genetics of osteosarcoma

JW Martin, JA Squire, M Zielenska - Sarcoma, 2012 - Wiley Online Library
Osteosarcoma is a primary bone malignancy with a particularly high incidence rate in
children and adolescents relative to other age groups. The etiology of this often aggressive …

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors

AA Sandberg, JA Bridge - Cancer genetics and cytogenetics, 2003 - Elsevier
In this Update, the cytogenetic and molecular genetic findings in osteosarcoma (OS) and
some related tumors published since our book appeared in 1994 [1] will be presented and …

DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

S Knuutila, AM Björkqvist, K Autio… - The American journal …, 1998 - ncbi.nlm.nih.gov
This review summarizes reports of recurrent DNA sequence copy number amplifications in
human neoplasms detected by comparative genomic hybridization. Some of the …

Osteosarcoma genetics and epigenetics: emerging biology and candidate therapies

JJ Morrow, C Khanna - Critical Reviews™ in Oncogenesis, 2015 - dl.begellhouse.com
Osteosarcoma is the most common primary malignancy of bone, typically presenting in the
first or second decade of life. Unfortunately, clinical outcomes for osteosarcoma patients …

Molecular pathogenesis of osteosarcoma

M Kansara, DM Thomas - DNA and cell biology, 2007 - liebertpub.com
Osteosarcoma is a devastating but rare disease, whose study has illuminated both the basic
biology and clinical management of cancer over the past 30 years. These contributions have …

[HTML][HTML] MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of …

F Dujardin, MBN Binh, C Bouvier, A Gomez-Brouchet… - Modern Pathology, 2011 - Elsevier
Low-grade osteosarcoma is a rare malignancy that may be subdivided into two main
subgroups on the basis of location in relation to the bone cortex, that is, parosteal …

TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT

A de Nonneville, S Salas, F Bertucci… - EMBO Molecular …, 2022 - embopress.org
In some types of cancer, telomere length is maintained by the alternative lengthening of
telomeres (ALT) mechanism. In many ALT cancers, the α‐thalassemia/mental retardation …